Houlihan Lokey Advises MEDIFOX DAN

Houlihan Lokey is pleased to announce that MEDIFOX DAN, a portfolio company of Hg Capital, and German market leader in out-of-hospital software solutions, has been acquired by ResMed in a US$1 billion transaction.

MEDIFOX DAN, a portfolio company of Hg, is a leading provider of digital solutions in the care, support, and therapy sectors, delivering high-quality outcomes for people in need, while simultaneously creating efficiency, more freedom for human interaction, as well as caregiver engagement.

MEDIFOX DAN’s clinical, financial, and operational solutions are mission-critical for those providing out-of-hospital care, including care documentation, personnel planning, administration, billing, and more. MEDIFOX DAN offers an end-to-end solution and is the operating system of choice used daily by more than 300,000 caregivers.

For ResMed, the acquisition of MEDIFOX DAN is a landmark transaction with strategic growth opportunities from unlocking thousands of providers and millions of patients and builds on ResMed’s existing business in Germany as a leading provider of innovative cloud-connected medical devices and home care services that transform care for patients with sleep apnoea and other respiratory conditions.

Houlihan Lokey served as the exclusive sellside advisor to Hg, being very familiar with the company, management, and Hg team, as the firm led a sale to Hg in 2018. The process attracted significant interest from global players, including both strategic players and large-cap financial sponsors with a healthcare and technology focus.